loading page

Bone marrow necrosis in pediatric malignancies - 10-year retrospective review and review of literature
  • +3
  • Michell Lozano-Chinga,
  • Lauren Draper,
  • Tracy George,
  • Archana Agarwal,
  • David Dansie,
  • Luke Maese
Michell Lozano-Chinga
Primary Children's Hospital

Corresponding Author:[email protected]

Author Profile
Lauren Draper
Saint Louis University
Author Profile
Tracy George
The University of Utah School of Medicine
Author Profile
Archana Agarwal
University of Utah
Author Profile
David Dansie
Primary Children's Hospital
Author Profile
Luke Maese
University of Utah School of Medicine
Author Profile


Bone marrow necrosis (BMN) is a rare pathologic finding, but when encountered is most often associated with malignancy. In adults its presence correlates with an inferior prognosis, however in children the prognostic implication is unclear. We performed a retrospective review of 3,760 bone marrow specimens in patients ≤ 18 years over a ten-year period. BMN was identified in less than 1% of specimens and only in patients with leukemia, lymphoma or neuroblastoma. BMN contributed to a delay in diagnosis; however, advanced medical imaging may serve as a tool to localize non-necrotic areas for bone marrow sampling, facilitating an expedited diagnosis.
08 Sep 2020Submitted to Pediatric Blood & Cancer
08 Sep 2020Submission Checks Completed
08 Sep 2020Assigned to Editor
10 Sep 2020Reviewer(s) Assigned
10 Oct 2020Review(s) Completed, Editorial Evaluation Pending
11 Oct 2020Editorial Decision: Revise Minor
26 Oct 20201st Revision Received
26 Oct 2020Submission Checks Completed
26 Oct 2020Assigned to Editor
28 Oct 2020Review(s) Completed, Editorial Evaluation Pending
28 Oct 2020Editorial Decision: Accept